In January 2013, the U.S. Food and Drug Administration approved NESINA for the treatment of type 2 diabetes in adults as an adjunct to diet and exercise. NESINA was invented by scientists at Takeda California, who used ALS Beamlines 5.0.2 and 5.0.3 to collect x-ray diffraction data.
